Psyence Biomedical (PBM) Times Interest Earned (2023 - 2025)

Psyence Biomedical's (PBM) quarterly Times Interest Earned came in at $547.67 in Q3 2025, up 75.42% year-on-year from $312.2 in Q3 2024, and up 75.42% quarter-over-quarter from $312.2 in Q3 2024.

Psyence Biomedical (PBM) Times Interest Earned (2023 - 2025) Analysis & Trends

Psyence Biomedical's Times Interest Earned history runs 3 years deep, the most recent figure standing at $547.67 for Q3 2025.

  • On a quarterly basis, Times Interest Earned rose 75.42% year-over-year to $547.67 in Q3 2025; TTM through Sep 2025 was -$3936.5, a N/A change from a year earlier, with the FY2026 full-year figure at -$653.51, down 66.0% from the prior year.
  • Times Interest Earned rose to $547.67 in Q3 2025 per PBM's latest filing, from $312.2 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $547.67 in Q3 2025 and bottomed at $7.31 in Q3 2023.
  • The 3-year median for Times Interest Earned is $312.2 (2024), against an average of $289.06.
  • Across the five-year window, Times Interest Earned surged 4173.17% in 2024 and soared 75.42% in 2025, its largest moves.
  • Year by year, Times Interest Earned stood at $7.31 in 2023, then jumped by 4173.17% to $312.2 in 2024, then soared by 75.42% to $547.67 in 2025.
  • Per Business Quant, the three latest PBM Times Interest Earned figures stand at $547.67 (Q3 2025), $312.2 (Q3 2024), and $7.31 (Q3 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 658.42
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 7.60
4 NuCana 279.75 Bn 279.75 Bn - -0.22
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.71
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.72
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -0.38
10 Psyence Biomedical 1.56 Mn 1.56 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 547.67
Sep 30, 2024 312.20
Sep 30, 2023 7.31